Correlation Between Pfizer and SPDR SSgA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and SPDR SSgA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and SPDR SSgA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and SPDR SSgA Ultra, you can compare the effects of market volatilities on Pfizer and SPDR SSgA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of SPDR SSgA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and SPDR SSgA.

Diversification Opportunities for Pfizer and SPDR SSgA

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and SPDR is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and SPDR SSgA Ultra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SPDR SSgA Ultra and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with SPDR SSgA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SPDR SSgA Ultra has no effect on the direction of Pfizer i.e., Pfizer and SPDR SSgA go up and down completely randomly.

Pair Corralation between Pfizer and SPDR SSgA

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the SPDR SSgA. In addition to that, Pfizer is 20.94 times more volatile than SPDR SSgA Ultra. It trades about -0.04 of its total potential returns per unit of risk. SPDR SSgA Ultra is currently generating about 0.31 per unit of volatility. If you would invest  3,753  in SPDR SSgA Ultra on August 28, 2024 and sell it today you would earn a total of  305.00  from holding SPDR SSgA Ultra or generate 8.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  SPDR SSgA Ultra

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
SPDR SSgA Ultra 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in SPDR SSgA Ultra are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, SPDR SSgA is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pfizer and SPDR SSgA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and SPDR SSgA

The main advantage of trading using opposite Pfizer and SPDR SSgA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, SPDR SSgA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SPDR SSgA will offset losses from the drop in SPDR SSgA's long position.
The idea behind Pfizer Inc and SPDR SSgA Ultra pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes